Skip to main content

OptiNose, Inc.

OPTNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001494650

OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding OptiNose, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of OPTN: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4950+1
Shares45.5M32.7M−12.9M (−28.3%)
Value$166.4M$119.5M−$46.9M (−28.2%)

New holders (7)

Institutions that held OptiNose, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to OPTN in Q3 2022
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP38,300$140.0K0.00%
HighTower Advisors, LLC30,235$111.0K0.00%
Squarepoint Ops LLC20,356$75.0K0.00%
Arete Wealth Advisors, LLC12,000$44.0K0.00%
Psagot Value Holdings Ltd. / (Israel)5,208$19.0K0.01%
China Universal Asset Management Co., Ltd.780$3.00K0.00%
Federated Hermes, Inc.207$1.00K0.00%

Sold out (6)

Institutions that held OptiNose, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of OPTN in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
MVM Partners LLP12,500,000$45.5M
D. E. Shaw & Co., Inc.90,077$329.0K
Walleye Capital LLC36,226$133.0K
Assenagon Asset Management S.A.16,911$62.0K
Jane Street Group, LLC15,734$58.0K
Simplex Trading, LLC163$0